Boulikas, Teni
Inst. of Molecular Medical Sciences,
United States
2025 Rank: 76,915
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,919 out of 212,967 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76,915 | 82,668 |
| Total Cites | 1,951 | 2,066 |
| H-index | 24 | 25 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 35 | 35 |
| Total Cites to Single Authored Papers | 1,758 | 1,847 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1,900 | 2,001 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 1,912 | 2,019 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1,700 | 1,726 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.20 |
| Self-Citation Percentage |
5.57%
|
|
Boulikas, Teni
Regulon Inc. (USA),
Greece
2024 Rank: 32,120
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,444 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32,120 | 35,714 |
| Total Cites | 5,094 | 5,300 |
| H-index | 32 | 33 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 2,098 | 2,201 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3,383 | 3,521 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,641 | 3,805 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,439 | 4,488 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
3.89%
|
|
Boulikas, Teni
Regulon Inc. (USA),
Greece
2023 Rank: 29,448
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,353 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29,448 | 33,105 |
| Total Cites | 4,959 | 5,165 |
| H-index | 32 | 33 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 2,046 | 2,149 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3,291 | 3,429 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,537 | 3,701 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,322 | 4,372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
3.99%
|
|
Boulikas, Teni
Regulon Inc. (USA),
Greece
2022 Rank: 26,662
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,221 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26,662 | 30,038 |
| Total Cites | 4,776 | 4,981 |
| H-index | 32 | 33 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 1,992 | 2,095 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3,189 | 3,327 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,415 | 3,579 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,175 | 4,224 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
4.12%
|
|
Boulikas, Teni
Regulon Inc. (USA),
Greece
2021 Rank: 25,387
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,167 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25,387 | 29,134 |
| Total Cites | 4,682 | 4,886 |
| H-index | 32 | 32 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 1,953 | 2,056 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3,118 | 3,256 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,341 | 3,504 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,102 | 4,151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
4.18%
|
|
Boulikas, Teni
Regulon Inc. (USA),
Greece
2020 Rank: 23,375
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1,133 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23,375 | 26,291 |
| Total Cites | 4,489 | 4,692 |
| H-index | 31 | 32 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 43 | 43 |
| Total Cites to Single Authored Papers | 1,899 | 2,002 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 2,990 | 3,128 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 3,192 | 3,355 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,935 | 3,984 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
4.33%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.